- Home
- MMA vs QTTB Comparison
MMA vs QTTB Comparison
Compare MMA & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- QTTB
- Stock Information
- Founded
- MMA 2013
- QTTB 2015
- Country
- MMA Australia
- QTTB United States
- Employees
- MMA N/A
- QTTB N/A
- Industry
- MMA
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- QTTB Health Care
- Exchange
- MMA Nasdaq
- QTTB Nasdaq
- Market Cap
- MMA 20.1M
- QTTB 23.3M
- IPO Year
- MMA 2024
- QTTB N/A
- Fundamental
- Price
- MMA $1.41
- QTTB $3.17
- Analyst Decision
- MMA
- QTTB Hold
- Analyst Count
- MMA 0
- QTTB 7
- Target Price
- MMA N/A
- QTTB $12.17
- AVG Volume (30 Days)
- MMA 374.8K
- QTTB 509.7K
- Earning Date
- MMA 01-01-0001
- QTTB 11-06-2025
- Dividend Yield
- MMA N/A
- QTTB N/A
- EPS Growth
- MMA N/A
- QTTB N/A
- EPS
- MMA N/A
- QTTB N/A
- Revenue
- MMA $407,412.00
- QTTB N/A
- Revenue This Year
- MMA N/A
- QTTB N/A
- Revenue Next Year
- MMA N/A
- QTTB N/A
- P/E Ratio
- MMA N/A
- QTTB N/A
- Revenue Growth
- MMA N/A
- QTTB N/A
- 52 Week Low
- MMA $0.60
- QTTB $1.35
- 52 Week High
- MMA $4.11
- QTTB $53.17
- Technical
- Relative Strength Index (RSI)
- MMA 48.96
- QTTB 62.55
- Support Level
- MMA $1.39
- QTTB $3.45
- Resistance Level
- MMA $1.70
- QTTB $3.98
- Average True Range (ATR)
- MMA 0.11
- QTTB 0.30
- MACD
- MMA -0.04
- QTTB 0.10
- Stochastic Oscillator
- MMA 6.06
- QTTB 61.35
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.